| |
|
|
|
|
|
|
|||
|
Blood, 19 February 2009, Vol. 113, No. 8, pp. 1639-1650. Prepublished online as a Blood First Edition Paper on October 10, 2008; DOI 10.1182/blood-2008-05-159665.
Submitted May 27, 2008
Department of Hematology and Molecular Medicine, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Science, Nagasaki, Japan * Corresponding author; email: masakoiw{at}nagasaki-u.ac.jp.
Radiation exposure is a possible predisposing factor for monoclonal gammopathy of undetermined significance (MGUS), but the association has been uncertain. We investigated the relationship between radiation exposure and MGUS prevalence by using data from the M-protein screening for Nagasaki atomic bomb survivors during 1988-2004. Radiation exposure was assessed by exposure distance from the hypocenter and exposure radiation dose. We computed prevalence ratios (PRs) and the 95% confidence intervals (CIs) adjusting for exposure age and sex. A total of 1082 MGUS were identified from 52525 participants. MGUS prevalence was significantly higher in people exposed at distance within 1.5 km than beyond 3.0 km (PR, 1.4; 95%CI, 1.1-1.9) among those exposed at ages 20 years or younger, but it was not found among those exposed at ages 20 years or older. MGUS prevalence was also significantly higher in people exposed to more than 0.1Gy than those exposed to less than 0.01Gy (PR, 1.7; 95%CI, 1.0-2.8) among those exposed at ages 20 years or younger. Thus, people exposed at younger age exhibited significantly high risk of MGUS when exposed to high radiation dose. There was no clear association between radiation exposure and the malignant progression of MGUS. Further detailed analysis is needed.
Related Article in Blood Online:
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2008 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||